298 related articles for article (PubMed ID: 19348559)
1. Influenza virus-like particle vaccines.
Haynes JR
Expert Rev Vaccines; 2009 Apr; 8(4):435-45. PubMed ID: 19348559
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
[TBL] [Abstract][Full Text] [Related]
3. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
[TBL] [Abstract][Full Text] [Related]
5. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
[TBL] [Abstract][Full Text] [Related]
6. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
Matassov D; Cupo A; Galarza JM
Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
[TBL] [Abstract][Full Text] [Related]
7. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
[TBL] [Abstract][Full Text] [Related]
8. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
9. Cell-based protein vaccines for influenza.
Cox MM
Curr Opin Mol Ther; 2005 Feb; 7(1):24-9. PubMed ID: 15732526
[TBL] [Abstract][Full Text] [Related]
10. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
Latham T; Galarza JM
J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
[TBL] [Abstract][Full Text] [Related]
11. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
[TBL] [Abstract][Full Text] [Related]
13. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza.
Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V
Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806
[TBL] [Abstract][Full Text] [Related]
15. Progress on baculovirus-derived influenza vaccines.
Cox MM
Curr Opin Mol Ther; 2008 Feb; 10(1):56-61. PubMed ID: 18228182
[TBL] [Abstract][Full Text] [Related]
16. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
17. Changing perspective on immunization against influenza.
Johansson BE; Brett IC
Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
[TBL] [Abstract][Full Text] [Related]
18. [Universal influenza vaccines: developments, prospects for use].
Tsybalova LM; Kiselev OI
Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
[TBL] [Abstract][Full Text] [Related]
19. Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.
Subathra M; Santhakumar P; Satyam Naidu S; Lakshmi Narasu M; Senthilkumar TM; Lal SK
Appl Biochem Biotechnol; 2014 Apr; 172(7):3635-45. PubMed ID: 24562978
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccines based on virus-like particles.
Kang SM; Song JM; Quan FS; Compans RW
Virus Res; 2009 Aug; 143(2):140-6. PubMed ID: 19374929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
